DIRUI(SZ:300396)2022-12-08 08:36Group 1: R&D and Product Development - The company has accumulated significant core technologies over 20 years, including automatic light tracking technology for urine analyzers and interference algorithms based on fuzzy technology [2] - Current R&D products include the CS-9200 fully automatic biochemical analysis line and the FUS-3000 fully automatic urine analysis workstation [2] Group 2: Distributor Management - Since the end of 2012, the company has actively adjusted its distributor management policy, focusing on selecting and supporting high-quality distributors [3] - The company has ceased direct supply to some distributors with low transaction volumes, transitioning them to secondary distributors [3] Group 3: Subsidiary Establishment - The company has established a wholly-owned subsidiary in Shanghai with a registered capital of RMB 20 million, focusing on the distribution of related medical device products [3] Group 4: Product Selection Recognition - In May 2014, the National Health and Family Planning Commission initiated the selection of excellent domestic medical equipment, evaluating 218 products and selecting 96 from 27 companies [4] - The company's products, including CS-1600 and CS-T300, were included in the list of selected excellent domestic medical equipment [4]